Does RISANKIZUMAB-RZAA Cause Dysgraphia? 10 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Dysgraphia have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
10
Reports of Dysgraphia with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
6
Hospitalizations
How Dangerous Is Dysgraphia From RISANKIZUMAB-RZAA?
Of the 10 reports, 6 (60.0%) required hospitalization.
Is Dysgraphia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Dysgraphia?
DIMETHYL (238)
PREGABALIN (233)
DALFAMPRIDINE (226)
FINGOLIMOD (222)
VALPROATE (199)
INTERFERON BETA-1A (191)
TOFACITINIB (185)
NATALIZUMAB (171)
PIMAVANSERIN (161)
TERIFLUNOMIDE (141)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Dysgraphia Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA